Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Enterprise Products Partners

Iron Mountain

Realty Income Corp

Cohen & Steers Quality Income Realty Fund

Saratoga Investment

Dividends are the focus of income investors. What exactly are they? Lots of confusion surround dividends as people approach them from the wrong perspective.

The Income Method: Understanding How Dividends Work

MedMen Enterprises Inc.

Tilray Brands

Candian cannabis giant Tilray, Inc. (NASDAQ: TLRY) announced Tuesday it has acquired the majority of the outstanding senior secured convertible notes of MedMen Enterprises Inc. (CSE:MMEN) (OTCQX: MMNFF) that were originally held by certain funds affiliated with Gotham Green Partners, LLC and other funds. The transaction is valued at $165.8 million.

Cantor Fitzgerald Says Tilray's Stake In MedMen One Of The Steps In The 'U.S.' Journey, Could Be Getting Close To Altria

Franklin Resources

Chevron

Edison

Flowers Foods

Gaming and Leisure Properties

Huntington Bancshares

Kinder Morgan

M.D.C. Holdings

Medical Properties Trust

Merck

Newmont Mining

Sturm, Ruger & Company

Retail Opportunity Investments

Unum

Vale S.A.

Valero Energy

Williams

Exxon Mobil

May-August, 2021, Kiplinger-Today listed eight-sets of stocks sorted as: best-buys for 2021, infrastructure-plays, value, growth, small-cap, high-yield, housing-bets, and cash-flow-gushers. Those eight "exceptional-dividend" articles revealed 86 equities. 76 pay-dividends. Kiplinger article-titles were, '21 Best Stocks to Buy'; '14 Best Infrastructure Stocks'; '16 Best Value; '10 Dividends-Growth'; '6 Small-Cap'; '10 High-Yield 4% or More;' '12 Housing; '10 Cash-Flow-Gushers.'

Kiplinger Exceptional August 2021 Dividends Features 13 Ideal Dogs

Agrify

Amplify Seymour Cannabis ETF

Cronos Group

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Scotts Miracle-Gro

Trulieve Cannabis Corp.

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Vice ETF

AdvisorShares Pure Cannabis ETF 

Alan Brochstein, a friend of the podcast and now a 3peat guest, is the founder of 420 Investor and New Cannabis Ventures. Thoughts on uplisting, the ETF MSOS, volume and valuation issues and confronting the California cannabis landscape.

Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast Transcript)

Amazon

British American Tobacco

Enbridge

Magellan Midstream Partners

Philip Morris

Value stocks have underperformed for 13 years and given up all their relative gains vs. growth since 1974. Both value bulls and bears have good reasons to argue value is about to have an epic decade or that the value factor is dead forever.

7 High-Yield Blue-Chips That Can Help You Retire Rich

Payout should be increased in second half of this month. Improving earnings and buyback program should help dividend.

Altria: Time For Dividend Raise

GlaxoSmithKline

LTC Properties

LyondellBasell Industries

Prudential Financial

Walgreens

With the pandemic causing much uncertainty in the economy, these high-yielding dividend stocks to buy could offer some reassurances. The post 7 High-Yield Dividend Stocks to Get You Through Market Volatility appeared first on InvestorPlace.

7 High-Yield Dividend Stocks to Get You Through Market Volatility

GW Pharmaceuticals

Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast)

Honeywell

Motorola Solutions

Nutrien

Ryanair Hlds

Suncor Energy

Pension funds are excluding these large-cap stocks from their portfolios because of a failure to abide by ESG best practices.

9 "Dirty" Stocks That Pensions Are Shunning

Polaris

The 3 Best Dividend Aristocrats Retirees Can Safely Buy After A Red Hot July

CareTrust REIT

Imperial Brands PLC

Omega Healthcare Investors

Sabra Health Care

Ventas

Welltower

There are always bargains to be had in bull and bear markets alike. In this article, I highlight 3 compelling buys with high dividends that are well covered.

3 Strong Buys For A Rich Retirement, Up To 9% Yield

Innovative Industrial Properties

Looking for dividends? These three stocks are still undervalued.

3 Risky Dividend Stocks I Feel Safe Owning

Apple

AbbVie

Abbott Labs

Blackrock Inc

Disney

Global X SuperDividend US ETF

Amplify CWP Dividend & Option Income ETF

Cohen & Steers Closed-End Opportunity Fund

Corning

My Dividend Growth Portfolio July Update: $500K Across 32 Holdings, 3 Buys, And 2 Sells

News for Altria Stock (MO)